SK4052002A3 - Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba - Google Patents

Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba Download PDF

Info

Publication number
SK4052002A3
SK4052002A3 SK405-2002A SK4052002A SK4052002A3 SK 4052002 A3 SK4052002 A3 SK 4052002A3 SK 4052002 A SK4052002 A SK 4052002A SK 4052002 A3 SK4052002 A3 SK 4052002A3
Authority
SK
Slovakia
Prior art keywords
carnitine
ginkgo biloba
propionyl
acetyl
composition
Prior art date
Application number
SK405-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of SK4052002A3 publication Critical patent/SK4052002A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SK405-2002A 1999-10-08 2000-10-02 Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba SK4052002A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999RM000618A IT1306722B1 (it) 1999-10-08 1999-10-08 Composizione per la prevenzione e/o il trattamento di disfunzionicircolatorie, comprendente derivati della l-carnitina ed estratti di
PCT/IT2000/000391 WO2001026666A2 (en) 1999-10-08 2000-10-02 Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba

Publications (1)

Publication Number Publication Date
SK4052002A3 true SK4052002A3 (en) 2002-09-10

Family

ID=11406992

Family Applications (1)

Application Number Title Priority Date Filing Date
SK405-2002A SK4052002A3 (en) 1999-10-08 2000-10-02 Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba

Country Status (21)

Country Link
US (1) US6641849B1 (es)
EP (1) EP1218022B1 (es)
AR (1) AR025790A1 (es)
AT (1) ATE237341T1 (es)
AU (1) AU780643B2 (es)
CA (1) CA2386770C (es)
CZ (1) CZ20021062A3 (es)
DE (1) DE60002226T2 (es)
DK (1) DK1218022T3 (es)
ES (1) ES2195939T3 (es)
HU (1) HU227042B1 (es)
IL (1) IL148963A0 (es)
IT (1) IT1306722B1 (es)
MX (1) MXPA02003501A (es)
NO (1) NO20021640L (es)
PL (1) PL199996B1 (es)
PT (1) PT1218022E (es)
SK (1) SK4052002A3 (es)
TN (1) TNSN00186A1 (es)
TR (1) TR200200948T2 (es)
WO (1) WO2001026666A2 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1316998B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori.
IT1317035B1 (it) * 2000-05-30 2003-05-26 Sigma Tau Healthscience Spa Integratore ad attivita' antiossidante comprendente unaalcanoilcarnitina ed una associazione di polifenoli estratti dal
KR20030088453A (ko) * 2001-03-09 2003-11-19 소시에떼 데 프로듀이 네슬레 소시에떼아노님 연령 관련 생리학적 부전 개선 및 수명 연장을 위한 조성물
ITRM20010708A1 (it) * 2001-12-04 2003-06-04 Sigma Tau Ind Farmaceuti Uso di una alcanoil l-carnitina per il trattamento della disfunzione erettile.
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
ATE497809T1 (de) 2004-05-18 2011-02-15 Bright Future Pharmaceutical Lab Ltd Myricitrin verbindungen zur behandlung von schlafstörungen
GB0411166D0 (en) * 2004-05-19 2004-06-23 Bionovate Ltd Treatment for asthma and arthritis
ITRM20040561A1 (it) * 2004-11-11 2005-02-11 Sigma Tau Ind Farmaceuti Uso della acetil l-carnitina in combinazione con propionil l-carnitina e sildenafil per il trattamento della disfunzione erettile.
AR070816A1 (es) * 2008-03-14 2010-05-05 Otsuka Pharma Co Ltd Farmaco de combinacion para tratar trastornos vasculares
AU2009315771A1 (en) * 2008-11-11 2010-05-20 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Compound useful for treating cellulite
US20110015154A1 (en) * 2009-07-20 2011-01-20 Kellermann Gottfried H Supporting acetylcholine function
US20110098265A1 (en) * 2009-10-28 2011-04-28 Neuroscience, Inc. Methods for reducing cravings and impulses associated with addictive and compulsive behaviors
CZ308282B6 (cs) * 2010-08-05 2020-04-15 Výzkumný ústav živočišné výroby, v. v. i. Krmný doplněk pro zvýšení libida kanců
CN102783568B (zh) * 2012-08-29 2014-05-14 山东中医药大学 一种饲料添加剂
PL2952209T3 (pl) * 2014-06-04 2018-07-31 Alfasigma S P A Jednorodne formulacje zawierające wielonienasycone kwasy tłuszczowe omega-3 (n-3 PUFA) i resweratrol do podawania doustnego

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254314B (it) * 1992-03-27 1995-09-14 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
DE9318632U1 (de) * 1993-12-06 1995-04-06 Emsa-Werke Wulf GmbH & Co, 48282 Emsdetten Vorrichtung zum Aufnehmen von Folienrollen
US6221356B1 (en) * 1996-12-13 2001-04-24 Viva America Marketing, Inc. Method of preparation of biologically active Ginkgo biloba product
WO1998033494A1 (en) 1997-02-04 1998-08-06 Kosbab John V Compositions and methods for prevention and treatment of vascular degenerative diseases
IT1294227B1 (it) * 1997-08-01 1999-03-24 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l-carnitina e alcoli alifatici a lunga catena utile per la prevenzione
IT1306130B1 (it) * 1999-04-16 2001-05-30 Sigma Tau Healthscience Spa Composizione comprendente una carnitina e glutatione, atta adaumentare l'assorbimento del glutatione sinergizzandone gli effetti.

Also Published As

Publication number Publication date
IL148963A0 (en) 2002-11-10
TNSN00186A1 (fr) 2005-11-10
ATE237341T1 (de) 2003-05-15
EP1218022A2 (en) 2002-07-03
US6641849B1 (en) 2003-11-04
CZ20021062A3 (cs) 2002-08-14
PL199996B1 (pl) 2008-11-28
MXPA02003501A (es) 2002-09-02
NO20021640D0 (no) 2002-04-05
WO2001026666A2 (en) 2001-04-19
ITRM990618A0 (it) 1999-10-08
AR025790A1 (es) 2002-12-11
AU780643B2 (en) 2005-04-07
HU227042B1 (en) 2010-05-28
DE60002226D1 (de) 2003-05-22
WO2001026666A3 (en) 2001-09-13
ES2195939T3 (es) 2003-12-16
PL354413A1 (en) 2004-01-12
ITRM990618A1 (it) 2001-04-08
CA2386770C (en) 2009-09-08
DK1218022T3 (da) 2003-08-11
DE60002226T2 (de) 2004-03-04
AU7945600A (en) 2001-04-23
HUP0203449A3 (en) 2005-04-28
NO20021640L (no) 2002-05-29
TR200200948T2 (tr) 2002-10-21
HUP0203449A2 (hu) 2003-02-28
PT1218022E (pt) 2003-09-30
IT1306722B1 (it) 2001-10-02
CA2386770A1 (en) 2001-04-19
EP1218022B1 (en) 2003-04-16

Similar Documents

Publication Publication Date Title
SK4052002A3 (en) Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba
DE69821123T2 (de) Diätzusammensetzung zur steigerung des metabolismus und zur linderung von oxydativem stress
AU2008258958B2 (en) Anti-fatigue Agents and Oral Compositions Containing Andrographolide as Active Ingredient
DE60015893T2 (de) Zusammensetzung enthaltend ein carnitine und glutathion, zur erhöhung der absorption von glutathion und zur synergisierung seiner effekte
SK3782001A3 (en) Combination of carnitines and resveratrol for prevention or treatment of cerebral and ageing disorders
BR112012009806B1 (pt) Preparação envolvendo aminoácidos e plantas e sua atividade na desintoxicação do álcool
PL194177B1 (pl) Kompozycja zawierająca acetylo-L-karnitynę i jej zastosowania
KR101666969B1 (ko) 레스베라트롤 및 타우린을 유효성분으로 포함하는 뇌신경질환 치료 및 신경세포 보호용 조성물
ITRM980433A1 (it) Composizione ad attivita' antiossidante antiproliferativa energetica e atta a migliorare l'utilizzazione metabolica del glucosio
PL201896B1 (pl) Zastosowanie propionylo-L-karnityny i kwercetyny
DE60025215T2 (de) L-acetylcarnitin und l-propionylcarnitin zusammensetzung zur verhütung und behandlung von nierenstörungen und nierenenkrankheit
EP1194186B1 (en) CARDIOACTIVE COMPOSITION COMPRISING L-CARNITINE AND ITS DERIVATIVES AND i CRATAEGUS /i EXTRACTS
RU2436415C2 (ru) Композиция биологически активных веществ на основе бетулина с регулируемой скоростью высвобождения компонентов для снижения степени алкогольного опьянения, предупреждения и снятия алкогольной интоксикации и похмельного синдрома
US20020002202A1 (en) Use of fumarate salt of L-carnitine or its alkanoyl derivatives in ischaemia
SK12402002A3 (sk) Kompozícia pre prevenciu a/alebo liečenie cievnych ochorení obsahujúca propionyl L-karnitín a koenzým Q10
EP1010429B1 (en) Pharmaceutical composition, in particular for dietetical use comprising a derivative of pyruvic acid and unripe bitter orange extract
PL202682B1 (pl) Kompozycja do zapobiegania i/lub leczenia zmian komórkowych i tkankowych i jej zastosowanie
TW200841827A (en) A nutritional supplement for adjustment of blood pressure and protection of cardio-vascular and cerebro-vascular systems
MXPA01003569A (es) Combinacion de carnitinas y resveratrol para prevenir o tratar enfermedades cerebrales y del envejecimiento